- Home
- FLXS vs VNDA Comparison
FLXS vs VNDA Comparison
Compare FLXS & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLXS
- VNDA
- Stock Information
- Founded
- FLXS 2001
- VNDA 2002
- Country
- FLXS United States
- VNDA United States
- Employees
- FLXS N/A
- VNDA N/A
- Industry
- FLXS Home Furnishings
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- FLXS Consumer Discretionary
- VNDA Health Care
- Exchange
- FLXS Nasdaq
- VNDA Nasdaq
- Market Cap
- FLXS 258.2M
- VNDA 249.4M
- IPO Year
- FLXS N/A
- VNDA 2006
- Fundamental
- Price
- FLXS $48.33
- VNDA $4.53
- Analyst Decision
- FLXS
- VNDA Strong Buy
- Analyst Count
- FLXS 0
- VNDA 2
- Target Price
- FLXS N/A
- VNDA $16.50
- AVG Volume (30 Days)
- FLXS 34.7K
- VNDA 346.2K
- Earning Date
- FLXS 10-20-2025
- VNDA 11-05-2025
- Dividend Yield
- FLXS 1.67%
- VNDA N/A
- EPS Growth
- FLXS 85.86
- VNDA N/A
- EPS
- FLXS 3.55
- VNDA N/A
- Revenue
- FLXS $441,073,000.00
- VNDA $203,467,000.00
- Revenue This Year
- FLXS $5.24
- VNDA $15.45
- Revenue Next Year
- FLXS $4.50
- VNDA $37.82
- P/E Ratio
- FLXS $13.48
- VNDA N/A
- Revenue Growth
- FLXS 6.86
- VNDA 11.78
- 52 Week Low
- FLXS $29.38
- VNDA $3.81
- 52 Week High
- FLXS $65.87
- VNDA $5.55
- Technical
- Relative Strength Index (RSI)
- FLXS 64.52
- VNDA 49.50
- Support Level
- FLXS $46.79
- VNDA $4.36
- Resistance Level
- FLXS $49.75
- VNDA $4.64
- Average True Range (ATR)
- FLXS 2.11
- VNDA 0.15
- MACD
- FLXS -0.31
- VNDA -0.02
- Stochastic Oscillator
- FLXS 69.41
- VNDA 29.46
About FLXS Flexsteel Industries Inc.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.